Clinical Trial Update: Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients [Phase 1]

View source ↗

Summary

This document reports a Phase 1 pharmacokinetic and pharmacodynamic study of pegfilgrastim in chemotherapy patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia
• Neutropenia

Drugs mentioned

• Pegfilgrastim (Neulasta) (pegfilgrastim)

Snippet

Sponsor: Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Conditions: Neutropenia | Phase 1 | Status: UNKNOWN